Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 16, 2011

Primary Completion Date

June 5, 2016

Study Completion Date

April 1, 2021

Conditions
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeTherapy-Related Acute Myeloid Leukemia
Interventions
DRUG

Bortezomib

Given SC

DRUG

Decitabine

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (53)

10029

Mount Sinai Hospital, New York

10065

NYP/Weill Cornell Medical Center, New York

11030

North Shore University Hospital, Manhasset

11040

Long Island Jewish Medical Center, New Hyde Park

11042

Northwell Health NCORP, Lake Success

Northwell Health/Center for Advanced Medicine, Lake Success

14263

Roswell Park Cancer Institute, Buffalo

19718

Christiana Care Health System-Christiana Hospital, Newark

19958

Beebe Medical Center, Lewes

20007

MedStar Georgetown University Hospital, Washington D.C.

21921

Christiana Care - Union Hospital, Elkton

27157

Wake Forest University Health Sciences, Winston-Salem

27534

Wayne Memorial Hospital, Goldsboro

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

27834

East Carolina University, Greenville

28204

Novant Health Presbyterian Medical Center, Charlotte

28501

Vidant Oncology-Kinston, Kinston

28791

Margaret R Pardee Memorial Hospital, Hendersonville

29316

Prisma Health Cancer Institute - Spartanburg, Boiling Springs

29605

Prisma Health Cancer Institute - Butternut, Greenville

Prisma Health Cancer Institute - Faris, Greenville

Prisma Health Greenville Memorial Hospital, Greenville

29615

Prisma Health Cancer Institute - Eastside, Greenville

29650

Prisma Health Cancer Institute - Greer, Greer

29672

Prisma Health Cancer Institute - Seneca, Seneca

32803

AdventHealth Orlando, Orlando

43210

Ohio State University Comprehensive Cancer Center, Columbus

46845

Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne

49017

Bronson Battle Creek, Battle Creek

49307

Spectrum Health Big Rapids Hospital, Big Rapids

49444

Mercy Health Mercy Campus, Muskegon

49503

Cancer Research Consortium of West Michigan NCORP, Grand Rapids

Mercy Health Saint Mary's, Grand Rapids

Spectrum Health at Butterworth Campus, Grand Rapids

49677

Spectrum Health Reed City Hospital, Reed City

49684

Munson Medical Center, Traverse City

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

60201

NorthShore University HealthSystem-Evanston Hospital, Evanston

60637

University of Chicago Comprehensive Cancer Center, Chicago

65212

University of Missouri - Ellis Fischel, Columbia

73071

Cancer Care Associates-Norman, Norman

73120

Mercy Hospital Oklahoma City, Oklahoma City

94040

Palo Alto Medical Foundation-Camino Division, Mountain View

06102

Hartford Hospital, Hartford

04330

Harold Alfond Center for Cancer Care, Augusta

04401

Eastern Maine Medical Center, Bangor

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Brigham and Women's Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

08103

Cooper Hospital University Medical Center, Camden

05602

Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners

05405

University of Vermont and State Agricultural College, Burlington

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01420926 - Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter